Guillain-Barre Syndrome Following Ad26.Cov2.S Covid-19 Vaccine: A Case Report

Journal of Nobel Medical College Pub Date : 2021-12-31 DOI:10.3126/jonmc.v10i2.41790

Sushmita Khanal, S. Khanal

引用次数: 0

Abstract

Guillain-Barre Syndrome has been reported as a rare side effect in the recipients of Johnson & Johnson®'s Janssen Ad26.COV2.S COVID-19 vaccine. We report a case of Guillain-Barre Syndrome in a 50 years old female following the administration of the aforementioned vaccine.

查看原文本刊更多论文

Ad26.Cow2.S新冠肺炎疫苗接种后格林-巴利综合征病例报告

据报道，格林-巴利综合征是强生公司(Johnson & Johnson®)Janssen Ad26.COV2受体的一种罕见副作用。COVID-19疫苗。我们报告一例格林-巴利综合征在一个50岁的女性后，上述疫苗的管理。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Nobel Medical College

自引率

0.00%

发文量

审稿时长

16 weeks